Concepedia

Author

Jian Wu

Zhejiang UniversityORCID

Also Known As

Diyu Chen, J Wu, J. Wu, J.X. Wu, JIAN WU, Jian Wu, Jian Xiang Wu, Jinmei Tan, Shigang Lv, Wu Jian

276

Publications

11.6K

Citations

54

H-Index

197

Concepts

All Affiliations

Zhejiang UniversityFirst Affiliated Hospital Zhejiang UniversityBlood Center of Zhejiang ProvinceMinistry of Public HealthZhejiang Cancer Hospital
JW

About

Jian Wu is an author at Zhejiang University specializing in medicine, cancer research, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

32

53

3.8K

2

Engineering

11

11

393

3

Health Sciences

8

8

220

4

Natural Sciences

3

3

250

5

Public Health

1

1

20

Jian Wu

×

154

Publications

10.5K

Citations

52

H-Index

YearCitations

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Zhenggang Ren, Jianming Xu, Yuxian Bai,

The Lancet Oncology

2021

1K

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

Yunhao Chen, Chuanhui Peng, Junru Chen,

Molecular Cancer

2019

656

Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial

Jianming Xu, Jie Shen, Shanzhi Gu,

Clinical Cancer Research

2020

549

Liver Transplantation for Hepatocellular Carcinoma

Shusen Zheng, Xiao Xu, Jian Wu,

Transplantation

2008

455

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Shukui Qin, Feng Bi, Shanzhi Gu,

Journal of Clinical Oncology

2021

383

MOF Nanoparticles with Encapsulated Autophagy Inhibitor in Controlled Drug Delivery System for Antitumor

Xuerui Chen, Rongliang Tong, Zheqi Shi,

ACS Applied Materials & Interfaces

2017

335

ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1

Yunhao Chen, Yanchun Zhao, Junru Chen,

Molecular Cancer

2020

296

ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway

Junru Chen, Chaofeng Ding, Yunhao Chen,

Cancer Letters

2020

208

PROTAC-DB: an online database of PROTACs

Gaoqi Weng, Chao Shen, Dongsheng Cao,

Nucleic Acids Research

2020

205

High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma

Beng Yang, Xiaode Feng, Hua Liu,

Oncogene

2020

192

Page 1